Skip to content

LIGHTING THE FIGHT AGAINST CHILDHOOD CANCER

Kate Amato Foundation Grant Awards

Elucidating the Role of Invariant Natural Killer T Cells in Neuroblastoma Antitumor Immunity

Elucidating the Role of Invariant Natural Killer T Cells in Neuroblastoma Antitumor Immunity

2019

Hamid Bassiri, MD

University of Pennsylvania and Children’s Hospital of Philadelphia (CHOP)

Transcriptional Addiction in Acute Myeloid Leukemia

Transcriptional Addiction in Acute Myeloid Leukemia

2019

Max Pimkin, MD, PhD

Dana Farber Cancer Institute, Boston Children’s Hospital, Harvard Medical School

The Role of the Macro lncRNA KCNQ1OT1 in Embryonal Rhabdomyosarcoma Tumorigenesis

The Role of the Macro lncRNA KCNQ1OT1 in Embryonal Rhabdomyosarcoma Tumorigenesis

2019

Corrine Linardic, MD, PhD

Duke University School of Medicine

Developing a pediatric B-ALL model to uncover epigenetic mechanisms of relapse from CAR-T cell immunotherapy

Developing a pediatric B-ALL model to uncover epigenetic mechanisms of relapse from CAR-T cell immunotherapy

2018

Dr. Patricia Ernst and Dr. Terry Fry

Human Immunology and Immunotherapy Initiative at University of Colorado School of Medicine and Children’s Hospital of Colorado

The Role of CXCL 10-CXCR3 AXIS in Osteosarcoma Metastasis

The Role of CXCL 10-CXCR3 AXIS in Osteosarcoma Metastasis

2018

Dr. Tsz-Kwong “Chris” Man

Cancer Genomics and Genetics Program at Baylor College of Medicine and Texas Children’s Cancer Center

Novel Targeted Therapy to Eliminate Leukemic Stem Cells in Pediatric Acute Myeloid Leukemia

Novel Targeted Therapy to Eliminate Leukemic Stem Cells in Pediatric Acute Myeloid Leukemia

2018

Dr. Martina Roos, Dr. Vivian Chang and Dr. John Chute

The David Geffen School of Medicine at UCLA

Be a part of Kate Amato Foundation

Donate today to help fund innovative pediatric cancer research